We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+9.18%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$605M
AUM Growth
+$125M
(+26%)
Cap. Flow
+$96.3M
Cap. Flow
% of AUM
15.91%
Top 10 Holdings %
Top 10 Hldgs %
10.86%
Holding
696
New
282
Increased
102
Reduced
88
Closed
224
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$7.1M |
| 2 |
Incyte
INCY
|
+$6.78M |
| 3 |
Target
TGT
|
+$5.96M |
| 4 |
ResMed
RMD
|
+$5.78M |
| 5 |
MSCI
MSCI
|
+$5.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$46.8M |
| 2 |
Wynn Resorts
WYNN
|
+$5.62M |
| 3 |
Apple
AAPL
|
+$5.53M |
| 4 |
Novartis
NVS
|
+$5.28M |
| 5 |
Walmart Inc
WMT
|
+$4.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 17.11% |
| 3 | Healthcare | 16.08% |
| 4 | Industrials | 11.44% |
| 5 | Financials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Tyson Foods
TSN
$20.4B
| $777K | 0.13% |
+15,225
| New | +$829K |
|
227
Liberty Global Class A
LBTYA
$3.62B
| $758K | 0.13% |
44,939
+10,409
| +30% | +$185K |
|
|
CUK
228
DELISTED
Carnival PLC
CUK
| $753K | 0.12% |
+44,438
| New | +$466K |
|
229
Illinois Tool Works
ITW
$82.6B
| $750K | 0.12% |
+2,999
| New | +$702K |
|
230
Protagonist Therapeutics
PTGX
$8.79B
| $748K | 0.12% |
+27,092
| New | +$678K |
|
|
P
231
Everpure Inc
P
$25.7B
| $741K | 0.12% |
+20,117
| New | +$570K |
|
232
Gilead Sciences
GILD
$162B
| $735K | 0.12% |
+9,540
| New | +$761K |
|
233
Bloom Energy
BE
$60.6B
| $734K | 0.12% |
44,909
+30,046
| +202% | +$486K |
|
234
Teledyne Technologies
TDY
$30.4B
| $733K | 0.12% |
+1,782
| New | +$735K |
|
235
Murphy USA
MUSA
$11.2B
| $724K | 0.12% |
+2,327
| New | +$652K |
|
236
Cincinnati Financial
CINF
$27.3B
| $721K | 0.12% |
+7,413
| New | +$766K |
|
237
Carvana
CVNA
$68.6B
| $716K | 0.12% |
138,195
-1,632,045
| -92% | -$4.53M |
|
238
Skyworks Solutions
SWKS
$9.37B
| $711K | 0.12% |
+6,422
| New | +$678K |
|
239
Omnicom Group
OMC
$21.6B
| $707K | 0.12% |
+7,426
| New | +$689K |
|
240
Biohaven
BHVN
$2.03B
| $704K | 0.12% |
+29,443
| New | +$507K |
|
241
Louisiana-Pacific
LPX
$5.06B
| $702K | 0.12% |
+9,365
| New | +$579K |
|
242
Integra LifeSciences
IART
$1.29B
| $700K | 0.12% |
+17,017
| New | +$819K |
|
243
Edwards Lifesciences
EW
$49.6B
| $696K | 0.12% |
7,382
-20,930
| -74% | -$1.82M |
|
244
Delek US
DK
$4.16B
| $695K | 0.11% |
+29,013
| New | +$659K |
|
|
PINC
245
DELISTED
Premier
PINC
| $695K | 0.11% |
+25,112
| New | +$717K |
|
246
Nucor
NUE
$58.6B
| $694K | 0.11% |
4,235
+1,665
| +65% | +$243K |
|
247
Amcor
AMCR
$20.8B
| $694K | 0.11% |
13,904
+6,605
| +90% | +$344K |
|
248
Doximity
DOCS
$3.76B
| $694K | 0.11% |
+20,387
| New | +$679K |
|
249
Tenet Healthcare
THC
$20.5B
| $689K | 0.11% |
+8,472
| New | +$603K |
|
250
A.O. Smith
AOS
$8.17B
| $685K | 0.11% |
+9,406
| New | +$644K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Seven Eight Capital held 696 positions worth $605M, up 26% from $480M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Seven Eight Capital deployed $96.3M of net new capital in Q2 2023, opening 282 new positions and adding to 102 existing holdings. Its largest new stake was AbbVie: 48,404 shares worth $6.52M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Carvana, an estimated $4.53M trimmed.
- Seven Eight Capital's largest Q2 2023 buy was AbbVie: 48,404 shares worth $6.52M.
- Seven Eight Capital added most to Las Vegas Sands in Q2 2023, an estimated $4.94M increase.
- Seven Eight Capital's biggest Q2 2023 reduction was Carvana, cutting an estimated $4.53M.
- Seven Eight Capital fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $46.8M.
- Seven Eight Capital's ten largest holdings make up 11% of its $605M portfolio in Q2 2023.
- Seven Eight Capital opened 282 new positions and closed 224 in Q2 2023.
- Seven Eight Capital's portfolio value rose 26% quarter-over-quarter to $605M.
Based on Seven Eight Capital's 13F filing for Q2 2023, filed 14 Aug 2023.